Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary Key Members of BioScrip’s Leadership Team to Continue in Executive Roles with Combined Company Following Close of Option Care Merger
DENVER , June 13, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip"), the largest independent national provider of infusion and home care management solutions, today announced that key members of BioScrip’s leadership team will continue in executive roles with the combined company
Toggle Summary BioScrip to Participate in Upcoming Investor Conferences
DENVER , May 21, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen M.
Toggle Summary BioScrip Reports First Quarter 2019 Financial Results
DENVER , May 02, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its first quarter 2019 financial results.                      First Quarter 2019
Toggle Summary BioScrip, Inc. Provides Merger Update
DENVER , April 23, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today provided an update on its proposed merger with Option Care Enterprises, Inc. (“Option Care”).
Toggle Summary BioScrip Reports Fourth Quarter and Full Year 2018 Financial Results
DENVER , March 15, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its fourth quarter and full year 2018 financial results.                               
Toggle Summary Home and Alternate Site Infusion Therapy Providers BioScrip and Option Care to Merge
Creates a Leading Independent Provider of Home and Alternate Site Infusion Services with  Deep Clinical Expertise and Broad Therapy Portfolio Enhanced Scale and Improved Financial Profile Expected to Enable Growth in Attractive and Growing Segment of U.S.
Toggle Summary BioScrip Reschedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call
DENVER , March 13, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company has rescheduled the release of its fourth quarter and full year 2018
Toggle Summary BioScrip Schedules Release of Fourth Quarter and Full Year 2018 Financial Results and Conference Call
DENVER , Feb. 25, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will issue its financial results press release for the fourth quarter
Toggle Summary BioScrip to Present at the 37th Annual J.P. Morgan Healthcare Conference
DENVER , Jan. 03, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, will present at the
Toggle Summary BioScrip to Host Analyst and Investor Day
DENVER , Nov. 26, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will host an Analyst and Investor Day on Thursday, December 6, 2018 in